Young people most at risk of rare blood clots after AstraZeneca vaccine
Published
Younger adults are most at risk of rare blood clotting after having the Oxford-AstraZeneca vaccine, the UK’s medicines regulator has said.
Full ArticlePublished
Younger adults are most at risk of rare blood clotting after having the Oxford-AstraZeneca vaccine, the UK’s medicines regulator has said.
Full ArticleYounger adults are particularly affected by the rare blood clotting disorder linked to the Oxford-AstraZeneca vaccine, the UK’s..
Figures suggest the risk of developing a rare blood clot is about four people in a million who receive the Oxford/AstraZeneca..